High Efficacy of Dupilumab in Omalizumab-Refractory Severe Chronic Spontaneous Urticaria and Delayed Pressure Urticaria.

Actas Dermosifiliogr

Universidad de Castilla La Mancha, Albacete, España; Servicio de Dermatología, Complejo Hospitalario Universitario de Toledo, Toledo, España.

Published: October 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ad.2023.07.038DOI Listing

Publication Analysis

Top Keywords

high efficacy
4
efficacy dupilumab
4
dupilumab omalizumab-refractory
4
omalizumab-refractory severe
4
severe chronic
4
chronic spontaneous
4
spontaneous urticaria
4
urticaria delayed
4
delayed pressure
4
pressure urticaria
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!